FF:0011101: Difference between revisions
From FANTOM5_SSTAR
(Created page with "{{F5terms
|id=FF:0011101
|name=CD14-positive monocytes - mock treated
|namespace=
|def=
|xref=
|is_a=CL:0002057;;EFO:0001746;;FF:0000002;;FF:0000210;;FF:0000343;;FF:0000...") |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{F5terms | {{F5terms | ||
| | |alt_id= | ||
|caged_opossum_human=http://cagedop.cmmt.ubc.ca/CAGEd_oPOSSUM/results/precomputed/human/FF:0011101/results.html | |||
| | |||
|comment= | |comment= | ||
|created_by= | |created_by= | ||
| | |def= | ||
|derives_from=CL:0002057 | |||
|derives_from= | |||
|develops_from= | |develops_from= | ||
|disjoint_from= | |||
|has_quality= | |has_quality= | ||
|id=FF:0011101 | |||
|is_a=EFO:0001746 ;;FF:0000343 ;;FF:0000350 ;;FF:0011111 | |||
|is_obsolete= | |||
|located_in= | |located_in= | ||
|name=human CD14-positive monocytes - mock treated sample | |||
|namespace=FANTOM | |||
|obo_creation_date= | |||
|part_of= | |part_of= | ||
|preceded_by= | |||
|property_value= | |property_value= | ||
| | |subset= | ||
| | |synonym= | ||
|union_of= | |||
|xref= | |||
}} | }} | ||
Latest revision as of 16:20, 18 April 2016
outline
- id: FF:0011101
- name: human CD14-positive monocytes - mock treated sample
- namespace: FANTOM
- CAGEd oPOSSUM: human
Ontology association
Parents
| is_a: | EFO:0001746(development or differentiation design),FF:0000343(control treatment sample),FF:0000350(experimentally modified sample),FF:0011111(human CD14-positive CD16-negative Monocytes sample) |
|---|---|
| derives_from: | CL:0002057(CD14-positive, CD16-negative classical monocyte) |
Children
| is a: | FF:11863-125A9 (CD14+ monocytes - mock treated, donor1),FF:11873-125C1 (CD14+ monocytes - mock treated, donor2),FF:11883-125D2 (CD14+ monocytes - mock treated, donor3) |
|---|
FF Samples
Human
- 11863-125A9 (CD14+ monocytes - mock treated, donor1)
- 11873-125C1 (CD14+ monocytes - mock treated, donor2)
- 11883-125D2 (CD14+ monocytes - mock treated, donor3)
